Clinical trial
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
NCT00088829 · Georgetown University, Other · Terminated
Key facts
| NCT number | NCT00088829 |
|---|---|
| Title | Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer |
| Official title | A Pilot Study to Establish a Standardized Protocol for Gene Microarray Analysis in Patients Receiving Neoadjuvant Chemotherapy for Breast Cancer: Identifying Factors Predictive of a Response to Paclitaxel |
| Lead sponsor | Georgetown University, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Genetic, Procedure |
| Interventions | paclitaxel, microarray analysis, biopsy, neoadjuvant therapy, Paclitaxel |
| Enrollment | 22 |
| Start date | Apr 1, 2001 |
| Primary completion | Dec 1, 2012 |
| Completion | Dec 1, 2012 |
| First posted | Aug 5, 2004 |
| Last update posted | Jul 11, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: